Marucci Anthony S's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 17, 2022
- Accession no.
- 0001415889-22-008769
- Filed
- Aug 17, 2022
- Trade date
- Aug 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.52M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marucci Anthony SCIK 0001429933 | Director, Officer (PRESIDENT & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +75,000 | $2.78 | +$208,500 | 102,692 | Direct | |
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +45,000 | $9.02 | +$405,900 | 147,692 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −120,000 | $37.66 | −$4,519,200 | 27,692 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseDisposed | −75,000 | $0.00 | $0 | 25,000 | Direct | |
| Aug 15, 2022 | Common Stock | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 26,665 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.